The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples